CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
Amazon Prime members in the US will now be able to have groceries delivered for free from a range of retailers, the group announced today. Prime members based in 3,500 cities across the US will be able to access the new benefit at no additional cost to the US$9.99 monthly subscription price.
Gautam Mukunda, lecturer in the practice of management at the Fletcher School of Law and Diplomacy, joins 'Squawk Box' to discuss Elon Musk's leadership at Tesla, whether he is the right person to lead the company going forward, and more.
First Bancorp (FBP) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.39 per share a year ago.
Option Care (OPCH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago.
Sandy Spring Bancorp (SASR) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $1.16 per share a year ago.
Shares of Pfizer and Viking Therapeutics have been on markedly different trajectories over the prior three years. In this comparison, Pfizer scans as a safer choice for cautious investors, while Viking Therapeutics may appeal to risk-tolerant growth investors.
Spotify beat expectations on the top and bottom lines when it reported quarterly earnings Tuesday, after a year of activist investor scrutiny and cost-cutting.
Extreme Networks Inc. NASDAQ: EXTR is a cloud-driven networking solutions provider that serves three seemingly “recession-proof” industries: government, education and healthcare. With nearly 40% of their revenues coming from government and education, this computer and technology sector company should fare relatively well even in uncertain macroeconomic conditions.
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
Cambridge (CATC) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.62 per share a year ago.